Ionis Pharmaceuticals (IONS) Reports Q4 EPS of $2.21, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. AXP
6. T
7. TMUS
8. CVS
9. UNH
10. SPY

Go back to Ionis Pharmaceuticals (IONS) Reports Q4 EPS of $2.21, Revenues Beat

Ionis Exceeds 2018 Financial Guidance

February 27, 2019 7:01 AM EST

CARLSBAD, Calif., Feb. 27, 2019 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today reported financial results for the fourth quarter and full year 2018 and reviewed highlights of its successful year.

"We begin 2019 in the strongest position in our 30-year history. Building on this foundation, we... More